The drugs — hydroxychloroquine sulfate and chloroquine phosphate — were deemed too risky and likely ineffective to treat COVID-19. ASSOCIATED PRESS The FDA in March issued an emergency use authorization for the anti-malaria drugs chloroquine and hydroxychloroquine for the treatment of COVID-19. Utah was able to cancel its order before it arrived, a representative for Utah’s Department of Health told HuffPost. In Ohio, “We are working on a plan now,” a health department representative told HuffPost. A representative for that state’s health department did not respond to HuffPost’s request for comment.

Source: Huffington Post June 18, 2020 18:22 UTC